Beyond Cholesterol: The Emerging Science of Plaque Stability For decades, the gold standard for cardiovascular health has been the management of blood cholesterol levels. The logic was simple: lower the lipids, lower the risk. However, a groundbreaking study from Cardiff University is shifting the conversation toward a more nuanced target: the stability of arterial plaques … Read more
The Social Pulse: Why Your Friendships Are Vital for Heart Health For decades, cardiovascular health has been viewed through the lens of cholesterol levels, blood pressure, and gym memberships. However, a shifting paradigm in cardiology suggests that our social circles may be just as critical as our diets. Experts are now confirming a strong correlation … Read more
The Shifting Landscape of Cardiogenic Shock For decades, the medical community has focused its efforts on ischemic cardiogenic shock (CS)—the sudden, massive heart failure that typically follows a heart attack. This focus has paid off. Data from the CDC WONDER database reveals a steady decline in deaths from heart attack-related CS between 1999 and 2020, … Read more
Understanding the “Hidden” Heart Risk: What is Lipoprotein(a)? When most of us think about heart health, we focus on “bad” cholesterol, known as LDL. However, there is a more elusive particle in the blood that often flies under the radar: Lipoprotein(a), or Lp(a). View this post on Instagram about Elevated Lp, Lipoprotein From Instagram — … Read more
The Shift Toward ‘Leave-Nothing-Behind’ Cardiology For decades, the gold standard for treating blocked arteries during a heart attack or unstable chest pain has been the drug-eluting stent (DES). These tiny metal mesh tubes are designed to keep arteries open permanently. However, a latest approach is gaining momentum: the “Leave-Nothing-Behind” strategy. This method utilizes sirolimus-eluting balloons … Read more
The Evolution of PAD Treatment: Moving Beyond Traditional Leg Bypass For millions of people living with peripheral arterial disease (PAD), the prospect of restoring blood flow to the legs has historically meant a difficult choice: minimally invasive endovascular therapies that may not be sufficient for complex blockages, or high-risk open surgical bypass surgery. However, a … Read more
Mount Sinai’s Adams Valve Institute: Pioneering a New Era in Heart Valve Care The Mount Sinai Health System has launched the Adams Valve Institute, a dedicated center focused on transforming the treatment of heart valve disease. This initiative builds upon decades of groundbreaking work led by Dr. David H. Adams, Chair of Cardiovascular Surgery at … Read more
Evolocumab: A New Era in Proactive Heart Disease Prevention? A groundbreaking analysis from the VESALIUS-CV trial, presented at the American College of Cardiology’s Annual Scientific Session, suggests a potential shift in how we approach heart disease prevention. The study reveals that evolocumab, a PCSK9 inhibitor, significantly reduced the risk of major cardiovascular events – by … Read more
Image via Unsplash. Debunking the Myth: COVID Vaccines and Sudden Death Risk The claim that COVID vaccines trigger sudden deaths in healthy young people gained significant traction, proving difficult to dispel. However, a recent, large-scale study indicates the opposite is true: COVID-19 vaccination is associated with a statistically significant lower risk of sudden death in … Read more
The AI Revolution in Cardiology: Beyond Diagnosis Cardiovascular disease remains a leading cause of death globally. But a recent wave of innovation, powered by deep learning and artificial intelligence, is poised to dramatically reshape how we understand, diagnose, and treat heart conditions. Recent advancements aren’t just about faster diagnoses; they’re about unlocking deeper insights into … Read more